FY2026 March Q3 Financial Results Briefing

Overview of Financial Results

In the consolidated Q3 FY2025 results, net sales amounted to 195.4 billion yen (12% YoY increase), operating income reached 45.0 billion yen (10% YoY increase), and net income was 35.0 billion yen (11% YoY increase). The third quarter alone recorded net sales of 65.3 billion yen (15% YoY increase), operating income of 15.4 billion yen (21% YoY increase), and net income of 12.2 billion yen (9% YoY increase), indicating growth in both revenue and profits. By segment, Functional Materials and Agricultural Chemicals achieved growth in both sales and profits, Chemicals declined in sales, and Healthcare remained flat.

Shareholder Returns and Outlook

The dividend forecast is set at 180 yen for the full year, a 6 yen increase from the previous year, with no changes from the forecast announced in November 2025. The company is conducting share buybacks totaling 10.5 billion yen, of which 1.5 billion yen was completed in April 2025 and 9.0 billion yen is planned to be completed by February 2026. The total return ratio is expected to be 78.8%. There are no revisions to the full-year earnings forecast since the November 2025 announcement, indicating a policy of stable growth and continued shareholder returns.